1. Home
  2. NEXA vs SPRY Comparison

NEXA vs SPRY Comparison

Compare NEXA & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexa Resources S.A.

NEXA

Nexa Resources S.A.

HOLD

Current Price

$9.70

Market Cap

1.0B

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$11.23

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEXA
SPRY
Founded
1956
2015
Country
Luxembourg
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
NEXA
SPRY
Price
$9.70
$11.23
Analyst Decision
Hold
Strong Buy
Analyst Count
5
4
Target Price
$6.20
$31.25
AVG Volume (30 Days)
715.4K
1.6M
Earning Date
02-19-2026
11-10-2025
Dividend Yield
1.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,839,970,000.00
$142,772,000.00
Revenue This Year
$4.43
N/A
Revenue Next Year
$2.11
$127.81
P/E Ratio
N/A
N/A
Revenue Growth
6.95
5459.66
52 Week Low
$4.44
$6.66
52 Week High
$9.55
$18.90

Technical Indicators

Market Signals
Indicator
NEXA
SPRY
Relative Strength Index (RSI) 73.34 57.22
Support Level $8.72 $10.95
Resistance Level $9.25 $11.82
Average True Range (ATR) 0.41 0.61
MACD 0.03 -0.02
Stochastic Oscillator 95.11 64.48

Price Performance

Historical Comparison
NEXA
SPRY

About NEXA Nexa Resources S.A.

Nexa Resources SA is a low-cost integrated zinc producer. It produces copper, silver, and gold as byproducts. The company operates through two segments namely Mining and Smelting. Its Mining segment consists of various operating units includes mineral exploration activities and the production of zinc concentrates, copper concentrates and concentrates. The Smelting segment comprises operating units which include facilities recovering and refining zinc metal out of feed materials such as zinc concentrates or secondary feed materials. It generates maximum revenue from the Smelting segment. Geographically It has a presence in Brazil, Peru, the United States of America, Switzerland, Japan, Argentina, South Korea, Colombia, Vietnam, Malaysia and other countries.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: